RxDoctor Payments Data

Sara Collins, MD

Cardiovascular Disease · Abington, PANPI 1558659250

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $424 of the $643 with a category attached, or 66.0%. 9 manufacturers reported payments, led by Abbott at 26.7% of the total. Reporting peaked in 2022 at $336 and has fallen 79.1% since, to $70 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in PA, where the typical reported total is $1,447.

$643in general payments, 2019–2025

Across 17 payments — averaging $37.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$172
  • Shockwave Medical, Inc$164
  • Pfizer$108
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$47
  • Johnson & Johnson$42
  • Inspire Medical Systems, Inc.$38
  • plus $72 from 3 others
$17,215in research payments, 2019–2025

Across 5 payments — averaging $3443.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cleerly, Inc.$17K

What the payments were for

  • Food & beverage$42466%
  • Education$21934%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$643 in reported general payments places this provider in the 30th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$44,371
Medicare patients
214
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Abington

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →